Effect of Red Meat Intake on Occurrence of Serum Non-transferrin Bound Iron (NTBI)
1 other identifier
interventional
15
1 country
1
Brief Summary
This study aims to evaluate the effect of red meat intake on occurrence of non-transferrin bound iron (NTBI)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started May 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 10, 2017
CompletedFirst Posted
Study publicly available on registry
January 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedJanuary 12, 2017
January 1, 2017
10 months
January 10, 2017
January 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of serum non-transferrin bound iron (NTBI) after consumption of red meat
Blood samples collected 2 h after consumption of red meat will be analyzed for non-transferrin bound iron (NTBI) concentration
2 hour post meal administration
Study Arms (1)
Beef
OTHERBeef topside fully cooked, 200g
Interventions
200 g beef topside which is fully cooked will be provided to participant after overnight fast. The intervention is one time only.
Eligibility Criteria
You may qualify if:
- Apparently healthy male volunteers (21 - 45 years old)
- C-reactive protein (CRP) \< 5 mg/L
You may not qualify if:
- Blood donation or significant blood loss (e.g. surgery) within the past 4 months
- Regular intake of iron and other nutrient supplements within the past 4 months
- Regular intake of medication except oral contraceptives
- Acute or recent inflammatory or infectious symptoms
- Chronic gastrointestinal disorders or metabolic diseases
- Smoking
- Coeliac disease or gluten-related disorders
- Iron deficiency anemia (Hb \< 14 g/dL for males) with serum ferritin concentration \< 30 ng/mL)
- Non-iron deficiency anemia (serum ferritin concentration within normal range (30 - 300 ng/mL for males) but low hemoglobin (\< 14 g/dL for males)
- Iron overload conditions (serum ferritin concentration \> 300 ng/mL for males)
- Known hereditary disorders of iron metabolism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Thomas Walczyklead
Study Sites (1)
National University of Singapore; National University Hospital
Singapore, Singapore
Related Publications (5)
Trumbo P, Yates AA, Schlicker S, Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc. 2001 Mar;101(3):294-301. doi: 10.1016/S0002-8223(01)00078-5. No abstract available.
PMID: 11269606BACKGROUNDMonsen ER, Hallberg L, Layrisse M, Hegsted DM, Cook JD, Mertz W, Finch CA. Estimation of available dietary iron. Am J Clin Nutr. 1978 Jan;31(1):134-41. doi: 10.1093/ajcn/31.1.134.
PMID: 619599BACKGROUNDPapanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005 Jan 15;202(2):199-211. doi: 10.1016/j.taap.2004.06.021.
PMID: 15629195BACKGROUNDHutchinson C, Al-Ashgar W, Liu DY, Hider RC, Powell JJ, Geissler CA. Oral ferrous sulphate leads to a marked increase in pro-oxidant nontransferrin-bound iron. Eur J Clin Invest. 2004 Nov;34(11):782-4. doi: 10.1111/j.1365-2362.2004.01416.x. No abstract available.
PMID: 15530152BACKGROUNDSchumann K, Kroll S, Romero-Abal ME, Georgiou NA, Marx JJ, Weiss G, Solomons NW. Impact of oral iron challenges on circulating non-transferrin-bound iron in healthy Guatemalan males. Ann Nutr Metab. 2012;60(2):98-107. doi: 10.1159/000336177. Epub 2012 Mar 6.
PMID: 22398912BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Walczyk, Ph.D
National University of Singapore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 10, 2017
First Posted
January 12, 2017
Study Start
May 1, 2016
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
January 12, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share